East Norriton, PA, United States of America

Kevin J Moriarity

This inventor holds 1 USPTO granted patent. Top assignee: Locus Pharmaceuticals, Inc.. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin J Moriarity. Retrieved from https://idiyas.com/inventor/kevin-j-moriarity

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin J Moriarity: Innovator in Dermatological Compounds

Introduction

Kevin J Moriarity is a notable inventor based in East Norriton, PA (US). He has made significant contributions to the field of dermatology through his innovative research and development of compounds aimed at treating skin conditions.

Latest Patents

Moriarity holds a patent for Aminopyrazine compounds, which are defined by a specific formula. This compound exhibits Itk inhibitory activity and is useful as a method for preventing and/or treating atopic dermatitis, among other applications. His work in this area highlights the potential for new treatments in dermatological care.

Career Highlights

Moriarity is associated with Locus Pharmaceuticals, Inc., where he continues to advance his research. His dedication to innovation in pharmaceuticals has positioned him as a key figure in the development of new therapeutic options.

Collaborations

Throughout his career, Moriarity has collaborated with talented individuals such as Rupa S Shetty and Martha Jean Kelly. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Kevin J Moriarity's contributions to the field of dermatology through his innovative patents and collaborations underscore his importance as an inventor. His work continues to pave the way for advancements in the treatment of skin conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…